BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10799657)

  • 1. Protective effect of L-deprenyl against apoptosis induced by okadaic acid in cultured neuronal cells.
    Suuronen T; Kolehmainen P; Salminen A
    Biochem Pharmacol; 2000 Jun; 59(12):1589-95. PubMed ID: 10799657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of PTEN expression in neuronal apoptosis.
    Kyrylenko S; Roschier M; Korhonen P; Salminen A
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):198-202. PubMed ID: 10581415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium.
    Paterson IA; Zhang D; Warrington RC; Boulton AA
    J Neurochem; 1998 Feb; 70(2):515-23. PubMed ID: 9453545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal sparing and behavioral effects of the antiapoptotic drug, (-)deprenyl, following kainic acid administration.
    Gelowitz DL; Paterson IA
    Pharmacol Biochem Behav; 1999 Feb; 62(2):255-62. PubMed ID: 9972692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. l-Deprenyl, blocking apoptosis and regulating gene expression in cultured retinal neurons.
    Xu L; Ma J; Seigel GM; Ma JX
    Biochem Pharmacol; 1999 Oct; 58(7):1183-90. PubMed ID: 10484076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K; Szende B
    Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells.
    Wu Y; Tada M; Takahata K; Tomizawa K; Matsui H
    Acta Med Okayama; 2007 Jun; 61(3):147-52. PubMed ID: 17593950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of R-(-)-deprenyl in adhesion of neuronal and non-neuronal cells].
    Jenei V; Zor K; Magyar K; Jakus J
    Orv Hetil; 2005 Mar; 146(13):601-6. PubMed ID: 15856624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-glucose deprivation-induced changes in organotypic cultures of the rat hippocampus.
    Bali B; Nagy Z; Kovács KJ
    Ideggyogy Sz; 2007 Mar; 60(3-4):140-3. PubMed ID: 17451055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A; McGeer PL
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition.
    Le W; Jankovic J; Xie W; Kong R; Appel SH
    Neurosci Lett; 1997 Mar; 224(3):197-200. PubMed ID: 9131670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells.
    Kuusisto E; Suuronen T; Salminen A
    Biochem Biophys Res Commun; 2001 Jan; 280(1):223-8. PubMed ID: 11162503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity.
    Seymour CB; Mothersill C; Mooney R; Moriarty M; Tipton KF
    Br J Cancer; 2003 Nov; 89(10):1979-86. PubMed ID: 14612913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.
    Mytilineou C; Radcliffe P; Leonardi EK; Werner P; Olanow CW
    J Neurochem; 1997 Jan; 68(1):33-9. PubMed ID: 8978707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurorescuing effects of the GAPDH ligand CGP 3466B.
    Waldmeier PC; Boulton AA; Cools AR; Kato AC; Tatton WG
    J Neural Transm Suppl; 2000; (60):197-214. PubMed ID: 11205140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of hydroxyl radical formation and protection of nigral neurons by l-deprenyl (selegiline).
    Wu RM; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1996 Jun; 786():379-90. PubMed ID: 8687036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective and neuronal rescue effects of (-)-deprenyl.
    Magyar K; Szende B; Lengyel J; Tarczali J; Szatmáry I
    J Neural Transm Suppl; 1998; 52():109-23. PubMed ID: 9564614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.